Last reviewed · How we verify
Gastrodia and Uncaria granule — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Gastrodia and Uncaria granule (Gastrodia and Uncaria granule) — Shanghai Institute of Hypertension.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Gastrodia and Uncaria granule TARGET | Gastrodia and Uncaria granule | Shanghai Institute of Hypertension | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Gastrodia and Uncaria granule CI watch — RSS
- Gastrodia and Uncaria granule CI watch — Atom
- Gastrodia and Uncaria granule CI watch — JSON
- Gastrodia and Uncaria granule alone — RSS
Cite this brief
Drug Landscape (2026). Gastrodia and Uncaria granule — Competitive Intelligence Brief. https://druglandscape.com/ci/gastrodia-and-uncaria-granule. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab